Jeffrey B Kopp
Overview
Explore the profile of Jeffrey B Kopp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
331
Citations
13712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Latt K, Yoshida T, Shrivastav S, Abedini A, Reece J, Sun Z, et al.
Am J Pathol
. 2024 Jul;
194(10):1844-1856.
PMID: 39032602
Although hyponatremia and salt wasting are common in patients with HIV/AIDS, the understanding of their contributing factors is limited. HIV viral protein R (Vpr) contributes to HIV-associated nephropathy. To investigate...
12.
Yoshida T, Myakala K, Jones B, Wang X, Shrivastav S, Santo B, et al.
Am J Physiol Renal Physiol
. 2024 Jul;
327(3):F450-F462.
PMID: 38961841
HIV disease remains prevalent in the United States and is particularly prevalent in sub-Saharan Africa. Recent investigations revealed that mitochondrial dysfunction in kidney contributes to HIV-associated nephropathy (HIVAN) in Tg26...
13.
Purswani M, Jacobson D, DiMeglio L, Yao T, Kopp J, Van Dyke R, et al.
J Pediatric Infect Dis Soc
. 2024 May;
13(8):396-405.
PMID: 38820092
Background: Tenofovir disoproxil fumarate (TDF) is often used in treating pregnant women living with HIV. Third-trimester TDF exposure is associated with a 12% reduction in bone mineral content in HIV-exposed...
14.
Yoshida T, Latt K, Santo B, Shrivastav S, Zhao Y, Fenaroli P, et al.
J Am Soc Nephrol
. 2024 May;
35(8):1058-1075.
PMID: 38709562
No abstract available.
15.
Choi H, Choi A, Kopp J, Winkler C, Cho S
J Korean Med Sci
. 2024 Apr;
39(14):e134.
PMID: 38622939
The global research and pharmaceutical community rapidly mobilized to develop treatments for coronavirus disease 2019 (COVID-19). Existing treatments have been repurposed and new drugs have emerged. Here we summarize mechanisms...
16.
Kudo K, Greer Y, Yoshida T, Harrington B, Korrapati S, Shibuya Y, et al.
Cancer Gene Ther
. 2024 Feb;
31(5):721-735.
PMID: 38424218
Ovarian cancer follows a characteristic progression pattern, forming multiple tumor masses enriched with cancer stem cells (CSCs) within the abdomen. Most patients develop resistance to standard platinum-based drugs, necessitating better...
17.
Mustafa K, Han Y, He D, Wang Y, Niu N, Jose P, et al.
PLoS One
. 2024 Feb;
19(2):e0295837.
PMID: 38335214
Poly-(ADP-ribose) polymerases (PARPs) are a protein family that make ADP-ribose modifications on target genes and proteins. PARP family members contribute to the pathogenesis of chronic inflammatory diseases, including atherosclerosis, in...
18.
Yang X, Delsante M, Daneshpajouhnejad P, Fenaroli P, Mandell K, Wang X, et al.
Lab Invest
. 2024 Jan;
104(5):100336.
PMID: 38266922
Chronic kidney disease progresses through the replacement of functional tissue compartments with fibrosis, a maladaptive repair process. Shifting kidney repair toward a physiologically intact architecture, rather than fibrosis, is key...
19.
Skitchenko R, Modrusan Z, Loboda A, Kopp J, Winkler C, Sergushichev A, et al.
medRxiv
. 2023 Dec;
PMID: 38076851
Focal segmental glomerulosclerosis (FSGS) is a common cause of nephrotic syndrome with an annual incidence in the United States in African-Americans compared to European-Americans of 24 cases and 5 cases...
20.
Gupta Y, Friedman D, McNulty M, Khan A, Lane B, Wang C, et al.
Nat Commun
. 2023 Nov;
14(1):7836.
PMID: 38036523
African Americans have a significantly higher risk of developing chronic kidney disease, especially focal segmental glomerulosclerosis -, than European Americans. Two coding variants (G1 and G2) in the APOL1 gene...